A case of primary biliary cholangitis overlapping with type 2 autoimmune hepatitis.
Adult
Alanine Transaminase
/ metabolism
Aspartate Aminotransferases
/ metabolism
Autoantibodies
/ immunology
Cholagogues and Choleretics
/ therapeutic use
Cholestasis
/ drug therapy
Female
Glucocorticoids
/ therapeutic use
Hepatitis, Autoimmune
/ drug therapy
Humans
Immunoglobulin G
/ immunology
Immunoglobulin M
/ immunology
Liver Cirrhosis, Biliary
/ drug therapy
Mitochondrial Proteins
/ immunology
Prednisolone
/ therapeutic use
Ursodeoxycholic Acid
/ therapeutic use
Anti-liver kidney microsomal antibody
Anti-mitochondrial antibody
Autoimmune hepatitis
Chronic nonsuppurative destructive cholangitis
Primary biliary cholangitis
Journal
Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
07
03
2019
accepted:
28
06
2019
pubmed:
10
7
2019
medline:
18
11
2020
entrez:
10
7
2019
Statut:
ppublish
Résumé
A 42-year-old woman was admitted to our hospital with cholestatic liver injury. Serological examination revealed anti-mitochondrial M2 antibody positivity and anti-nuclear antibody and anti-smooth muscle antibody negativity. Histological examination of the first liver biopsy revealed chronic nonsuppurative destructive cholangitis with epithelioid granulomas. Ursodeoxycholic acid therapy successfully treated her cholestasis. Sixteen months later, she developed acute icteric hepatitis with elevation of serum aspartate and alanine aminotransferase levels. Anti-mitochondrial M2 positivity and anti-nuclear antibody and anti-smooth muscle antibody negativity persisted at that time. However, it became clear that anti-liver kidney microsomal type 1 antibody was positive. Histological examination of the second liver biopsy demonstrated scarce interface hepatitis and evident parenchymal inflammation and centrilobular zonal necrosis. Her liver biochemical test results promptly improved with the addition of prednisolone therapy. Considering the findings, she was diagnosed with primary biliary cholangitis-type 2 autoimmune hepatitis overlap syndrome. According to a literature review, this is an extremely rare autoimmune overlap syndrome.
Identifiants
pubmed: 31286423
doi: 10.1007/s12328-019-01017-2
pii: 10.1007/s12328-019-01017-2
doi:
Substances chimiques
Autoantibodies
0
Cholagogues and Choleretics
0
Glucocorticoids
0
Immunoglobulin G
0
Immunoglobulin M
0
Mitochondrial Proteins
0
anti-liver kidney microsome antibody
0
Ursodeoxycholic Acid
724L30Y2QR
Prednisolone
9PHQ9Y1OLM
Aspartate Aminotransferases
EC 2.6.1.1
Alanine Transaminase
EC 2.6.1.2
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
79-82Références
J Clin Pathol. 2017 Nov;70(11):961-969
pubmed: 28428284
Hepatology. 1987 Nov-Dec;7(6):1333-9
pubmed: 3679093
BMC Gastroenterol. 2012 Jul 20;12:92
pubmed: 22816667
Gastroenterology. 1976 Sep;71(3):444-9
pubmed: 950095
Hepatology. 1999 Apr;29(4):1078-84
pubmed: 10094950
Hepatology. 1998 Aug;28(2):296-301
pubmed: 9695990
Clin Pediatr (Phila). 2016 May;55(5):479-82
pubmed: 26025341
Hepatol Res. 2014 Jan;44 Suppl S1:71-90
pubmed: 24397841
Virchows Arch A Pathol Anat Histol. 1977 Mar 11;373(2):143-60
pubmed: 139750
J Hepatol. 1999 Mar;30(3):394-401
pubmed: 10190720
J Clin Pathol. 2006 Mar;59(3):246-9
pubmed: 16505273
J Hepatol. 1999 Nov;31(5):929-38
pubmed: 10580593
Hepatology. 2008 Jul;48(1):169-76
pubmed: 18537184